Dominant transplantation tolerance: Opinion

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 499-506

  Graca, Luis ^a   Le Moine, Alain ^a,b   Cobbold, Stephen P ^a   Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASILIXIMAB; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD45 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEME OXYGENASE 1; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MARKER; MONOCLONAL ANTIBODY; OKT 4; OKT 8; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTIGENICITY; AUTOIMMUNITY; CELL CLONE; CELL DEATH; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL POPULATION; CELL PROLIFERATION; DENDRITIC CELL; DNA MICROARRAY; DONOR; DRUG POTENCY; EFFECTOR CELL; ENTERITIS; GENE EXPRESSION; GENETIC ASSOCIATION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HOST; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTOPENIA; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; NONHUMAN; PHENOTYPE; PURIFICATION; REGULATORY MECHANISM; REVIEW; SKIN GRAFT; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSPLANTATION TOLERANCE;

EID: 0141629548     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00098-0     Document Type: Review

References (89)

1. Waldmann H. Reprogramming the immune system. Immunol Rev. 185:2002;227-235.
2. Li X.C., Strom T.B., Turka L.A., Wells A.D. T cell death and transplantation tolerance. Immunity. 14:2001;407-416.
3. Graca L, Le Moine A, Cobbold SP, Waldmann H: Antibody-induced transplantation tolerance: the role of dominant regulation. Immunol Res 2003, in press.
4. Waldmann H., Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol. 16:1998;619-644.
5. + regulatory cells? Immunity. 14:2001;399-406.
6. Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol. 3:2003;123-132.
7. Qin S.X., Wise M., Cobbold S.P., Leong L., Kong Y.C., Parnes J.R., Waldmann H. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol. 20:1990;2737-2745.
8. Scully R., Qin S., Cobbold S., Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol. 24:1994;2383-2392.
9. Graca L., Honey K., Adams E., Cobbold S.P., Waldmann H. Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol. 165:2000;4783-4786.
10. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. Infectious transplantation tolerance. Science. 259:1993;974-977.
11. Chen Z.K., Cobbold S.P., Waldmann H., Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation. 62:1996;1200-1206.
12. Chen Z., Cobbold S., Metcalfe S., Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol. 22:1992;805-810.
13. Lehmann M., Graser E., Risch K., Hancock W.W., Muller A., Kuttler B., Hahn H.J., Kupiec-Weglinski J.W., Brock J., Volk H.D. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation. 64:1997;1181-1187.
14. Marshall S.E., Cobbold S.P., Davies J.D., Martin G.M., Phillips J.M., Waldmann H. Tolerance and suppression in a primed immune system. Transplantation. 62:1996;1614-1621.
15. Davies J.D., Leong L.Y., Mellor A., Cobbold S.P., Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol. 156:1996;3602-3607.
16. Wong W., Morris P.J., Wood K.J. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation. 63:1997;1490-1494.
17. + T cell tolerance and linked suppression. J Immunol. 163:1999;4805-4810.
18. + suppressor cell and its mechanisms of action. J Exp Med. 171:1990;141-157.
19. low subset. J Exp Med. 172:1990;1701-1708.
20. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1995;1151-1164.
21. Zelenika D., Adams E., Humm S., Graca L., Thompson S., Cobbold S.P., Waldmann H. Regulatory T cells over-express a subset of Th2 gene transcripts. J Immunol. 168:2002;1069-1079 This paper describes the gene expression profiles of Th1-, Th2- and Tr1-like clones with the same antigenic specificity.
22. + T cells.
23. - regulatory T cells. Proc Natl Acad Sci USA. 99:2002;13031-13036.
24. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol. 169:2002;2461-2465.
25. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 167:2001;1945-1953.
26. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., Morris P.J., Powrie F., Wood K.J. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 166:2001;3789-3796.
27. - T cells from tolerant and naïve mice.
28. + CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol. 163:1999;5353-5357.
29. Taylor P.A., Lees C.J., Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:2002;3493-3499.
30. Cohen J.L., Trenado A., Vasey D., Klatzmann D., Salomon B.L. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 196:2002;401-406.
31. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 196:2002;389-399.
32. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10- dependent immunoregulation of alloresponses. J Immunol. 168:2002;1080-1086.
33. van Maurik A., Herber M., Wood K.J., Jones N.D. Cutting edge: CD4(+)CD25(+) alloantigen-specific immunoregulatory cells that can prevent CD8(+) T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol. 169:2002;5401-5404.
34. van Maurik A., Wood K.J., Jones N.D. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. Transplantation. 74:2002;740-743.
35. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 166:2001;3008-3018.
36. + T cell numbers. J Immunol. 169:2002;4850-4860.
37. Barthlott T., Kassiotis G., Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med. 197:2003;451-460 This is an important paper, showing that competition for homeostatic expansion can resemble T-cell regulation.
38. + T cells is not sufficient to release effector cells from immune regulation.
39. ••].
40. ••].
41. + T cells with regulatory function.
42. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol Rev. 182:2001;68-79.
43. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med. 196:2002;1335-1346.
44. + T cells. J Exp Med. 184:1996;19-29.
45. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
46. + T cells or B cells. J Immunol. 161:1998;1868-1874.
47. - regulatory T cells. J Immunol. 161:1998;5193-5202.
48. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med. 6:2000;782-789.
49. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med. 195:2002;695-704.
50. Lechler R.I., Garden O.A., Turka L.A. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol. 3:2003;147-158.
51. Li Y., Li X.C., Zheng X.X., Wells A.D., Turka L.A., Strom T.B. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med. 5:1999;1298-1302.
52. Wells A.D., Li X.C., Li Y., Walsh M.C., Zheng X.X., Wu Z., Nunez G., Tang A., Sayegh M., Hancock W.W.et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med. 5:1999;1303-1307.
53. Sawitzki B., Lehmann M., Vogt K., Risch K., Brock J., Kupiec-Weglinski J.W., Volk H.D. Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Eur J Immunol. 32:2002;800-809.
54. + T cell subsets in determining transplantation rejection and tolerance. Immunol Rev. 182:2001;164-179.
55. Lin C.Y., Graca L., Cobbold S.P., Waldmann H. Dominant transplantation tolerance impairs CD8(+) T cell function but not expansion. Nat Immunol. 3:2002;1208-1213 Although most in vitro assays for regulatory function depend on the inhibition of proliferation, the action of regulatory T cells in vivo need not target proliferation, but rather the effector function of target T cells.
56. + T cells. Proc Natl Acad Sci USA. 99:2002;8832-8837.
57. Davies J.D., Martin G., Phillips J., Marshall S.E., Cobbold S.P., Waldmann H. T cell regulation in adult transplantation tolerance. J Immunol. 157:1996;529-533.
58. Onodera K., Hancock W.W., Graser E., Lehmann M., Sayegh M.H., Strom T.B., Volk H.D., Kupiec-Weglinski J.W. Type 2 helper T cell-type cytokines and the development of 'infectious' tolerance in rat cardiac allograft recipients. J Immunol. 158:1997;1572-1581.
59. + suppressor T cells that are not dependent upon IL-4. J Immunol. 161:1998;5147-5156.
60. + T cells. J Exp Med. 183:1996;2669-2674.
61. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 192:2000;295-302.
62. Piccirillo C.A., Letterio J.J., Thornton A.M., McHugh R.S., Mamura M., Mizuhara H., Shevach E.M. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 196:2002;237-246.
63. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T.W., Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 192:2000;303-310.
64. Sanchez-Fueyo A., Weber M., Domenig C., Strom T.B., Zheng X.X. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol. 168:2002;2274-2281.
65. + T cells is controlled by GITR.
66. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A.H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 196:2002;255-260.
67. Dieckmann D., Bruett C.H., Ploettner H., Lutz M.B., Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med. 196:2002;247-253.
68. Csizmadia V., Gao W., Hancock S.A., Rottman J.B., Wu Z., Turka L.A., Siebenlist U., Hancock W.W. Differential NF-kappaB and IkappaB gene expression during development of cardiac allograft rejection versus CD154 monoclonal antibody-induced tolerance. Transplantation. 71:2001;835-840.
69. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med. 8:2002;582-587.
70. el-Sawy T., Fahmy N.M., Fairchild R.L. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol. 14:2002;562-568.
71. Graca L., Cobbold S.P., Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med. 195:2002;1641-1646 The authors demonstrate that regulatory T cells can be located within tolerated allografts.
72. Soares M.P., Brouard S., Smith R.N., Bach F.H. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev. 184:2001;275-285.
73. Coito A.J., Kupiec-Weglinski J.W. Extracellular matrix proteins in organ transplantation. Transplantation. 69:2000;2465-2473.
74. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K.et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:2002;677-687.
75. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:2002;583-591.
76. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., Marshall B., Chandler P., Antonia S.J., Burgess R.et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 297:2002;1867-1870.
77. Mellor A.L., Keskin D.B., Johnson T., Chandler P., Munn D.H. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol. 168:2002;3771-3776 This paper describes a mechanism by which APCs can regulate T-cell responses distinct from the modulation of co-stimulation.
78. + T cells on components of the innate immune system.
79. + regulatory T cells can be switched off by DCs depending on inflammatory stimuli.
80. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 197:2003;403-411.
81. Le Moine A., Surquin M., Demoor F.X., Noel J.C., Nahori M.A., Pretolani M., Flamand V., Braun M.Y., Goldman M., Abramowicz D. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. J Immunol. 163:1999;3778-3784.
82. Le Moine A., Flamand V., Demoor F.X., Noel J.C., Surquin M., Kiss R., Nahori M.A., Pretolani M., Goldman M., Abramowicz D. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest. 103:1999;1659-1667.
83. Saiura A., Mataki C., Murakami T., Umetani M., Wada Y., Kohro T., Aburatani H., Harihara Y., Hamakubo T., Yamaguchi T.et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation. 72:2001;320-329.
84. Christopher K., Mueller T.F., Ma C., Liang Y., Perkins D.L. Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol. 169:2002;522-530.
85. Fairchild P.J., Waldmann H. Dendritic cells and prospects for transplantation tolerance. Curr Opin Immunol. 12:2000;528-535.
86. Jonuleit H., Schmitt E., Steinbrink K., Enk A.H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:2001;394-400.
87. Wise M.P., Bemelman F., Cobbold S.P., Waldmann H. Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol. 161:1998;5813-5816.
88. Lechner O., Lauber J., Franzke A., Sarukhan A., von Boehmer H., Buer J. Fingerprints of anergic T cells. Curr Biol. 11:2001;587-595.
89. - T cells.